Cell therapy Processing Market Report 2025 (Global Edition)

Global Cell therapy Processing Market Report 2025 Market Size Split by Offering Type Outlook: (Products, Services, Software), by Application Outlook: (Cardiovascular Devices, Bone Repair, Neurological...

Cell therapy Processing Market Report Description

We have various report editions of Cell therapy Processing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Cell therapy Processing Market Insights Video

Competitive Landscape of the Cell therapy Processing Market

The Cell Therapy Processing Market is highly competitive, with numerous established companies, innovative startups, and research institutions playing a significant role in its development. Key players in this market are focusing on advancements in technology, strategic partnerships, and expanding their product portfolios to maintain a competitive edge.

In October 2023, Nkarta, Inc. announced the FDA's approval of an IND application to investigate NKX019, its allogeneic, CD19-directed CAR NK cell therapy candidate, to cure lupus nephritis. (Source: https://ir.nkartatx.com/news-releases/news-release-details/nkarta-receives-fda-clearance-ind-application-nkx019-lupus) In June 2023, Vertex Pharmaceuticals Incorporated and Lonza revealed a joint venture to facilitate the manufacturing of Vertex's portfolios of investigational stem cell therapies. These therapies are designed to aid individuals with Type 1 Diabetes (T1D), with a specific focus on the VX-880 and VX-264 programs currently undergoing clinical trials. (Source: https://news.vrtx.com/news-releases/news-release-details/vertex-and-lonza-build-dedicated-manufacturing-facility-type-1)

Top Companies Market Share in Cell therapy Processing Industry: (In no particular order of Rank)

• Novartis AG
• Gilead Sciences
• Inc.
• Bristol-Myers Squibb Company
• Johnson & Johnson Services
• Inc
• JCR Pharmaceuticals Co.
• Ltd.
• JW Therapeutics
• Atara Biotherapeutics
• Anterogen Co.
• Ltd.
• MEDIPOST
• S. BIOMEDICS
• Aurion Biotech
• Holostem Terapie Avanzate S.r.l
• Nkarta
• Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Cell therapy Processing Market

Which Region Dominates the Cell therapy Processing Market in 2024?

According to Cognitive Market Research, North America dominates the Cell Therapy Processing Market due to several key factors, including advanced healthcare infrastructure, high research and development (R&D) investments, and a well-established biopharmaceutical industry. The region is home to numerous leading biotechnology and pharmaceutical companies, which actively invest in the development and commercialization of cell therapies.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is the fastest-growing region in the Cell Therapy Processing Market due to a combination of factors, including rapidly improving healthcare infrastructure, increasing investment in biotechnology, and a large, diverse patient population with unmet medical needs. The region's growing focus on advancing regenerative medicine and cell therapies, supported by government initiatives and funding, is driving market growth.

The current report Scope analyzes Cell therapy Processing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Cell therapy Processing Market Analysis

According to Cognitive Market Research, the global Cell therapy Processing market size was estimated at USD 4715.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1886.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Cell therapy Processing market with a market size of USD 1488.21million in 2024 and is projected to grow at a CAGR of 21.2%during the forecast period. The U.S. market's advancements in healthcare infrastructure, significant investments in biotechnology, and strong support for regenerative medicine.
• The Canada Cell therapy Processing market had a market share of USD 226.34million in 2024 and is projected to grow at a CAGR of 22.2%during the forecast period. Canada’s advancements in healthcare infrastructure, significant investments in biotechnology, and strong support for regenerative medicine.
• The Mexico Cell therapy Processing market is projected to witness growth at a CAGR of 21.9%during the forecast period, with a market size of USD 171.64million in 2024.

Europe Cell therapy Processing Market Analysis

According to Cognitive Market Research, the global Cell therapy Processing market size was estimated at USD 4715.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1414.65 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2031.

• The United Kingdom Cell therapy Processing market had a market share of USD 237.66million in 2024 and is projected to grow at a CAGR of 22.5%during the forecast period. In the UK, Cell therapy Processing sales witness an upswing due to the robust research initiatives, public-private collaborations, and a growing emphasis on personalized medicine.
• The France Cell therapy Processing market is projected to witness growth at a CAGR of 20.9%during the forecast period, with a market size of USD 130.15million in 2024.
• According to Cognitive Market Research, the German Cell therapy Processing market size was valued at USD 280.10million in 2024 and is projected to grow at a CAGR of 21.9%during the forecast period. In Germany, Cell therapy Processing surged due to the robust research initiatives, public-private collaborations, and a growing emphasis on personalized medicine.
• The Italy Cell therapy Processing market is projected to witness growth at a CAGR of 21.1%during the forecast period, with a market size of USD 121.66million in 2024.
• The Russia Cell therapy Processing market is projected to witness growth at a CAGR of 20.7%during the forecast period, with a market size of USD 219.27million in 2024.
• The Spain Cell therapy Processing market is projected to witness growth at a CAGR of 20.8% during the forecast period with a market size of USD 116.00million in 2024
• The Luxembourg Cell therapy Processing market is projected to witness growth at a CAGR of 21.8%during the forecast period, with a market size of USD 43.85million in 2024.
• The Portugal Cell therapy Processing market is projected to witness growth at a CAGR of 21.5%during the forecast period, with a market size of USD 29.71million in 2024.
• The Greece Cell therapy Processing market is projected to witness growth at a CAGR of 22.0%during the forecast period, with a market size of USD 16.98million in 2024.
• The Rest of Europe's Cell therapy Processing market is projected to witness growth at a CAGR of 20.4% during the forecast period, with a market size of USD 219.27million in 2024.

Asia Pacific Cell therapy Processing Market Analysis

According to Cognitive Market Research, the global Cell therapy Processing market size was estimated at USD 4715.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1084.57 million in 2024 and will grow at a compound annual growth rate (CAGR) of 25.2% from 2024 to 2031.

• According to Cognitive Market Research, the China Cell therapy Processing market size was valued at USD 488.05million in 2024 and is projected to grow at a CAGR of 24.7%during the forecast period. Cell therapy Processing surged in China due to rapid advancements in biotechnology, growing healthcare infrastructure, and increasing government support for regenerative medicine.
• The Japan Cell therapy Processing market is projected to witness growth at a CAGR of 23.7%during the forecast period, with a market size of USD 149.67million in 2024.
• The India Cell therapy Processing market had a market share of USD 130.15million in 2024 and is projected to grow at a CAGR of 27.0%during the forecast period. India's rapid advancements in biotechnology, growing healthcare infrastructure, and increasing government support for regenerative medicine.
• The South Korean Cell therapy Processing market is projected to witness growth at a CAGR of 24.3%during the forecast period, with a market size of USD 108.46million in 2024.
• The Australian Cell therapy Processing market is projected to witness growth at a CAGR of 24.9%during the forecast period, with a market size of USD 56.40million in 2024.
• The South East Asia Cell therapy Processing market is projected to witness growth at a CAGR of 26.2%during the forecast period, with a market size of USD 74.83million in 2024.
• The Rest of Asia Pacific Cell therapy Processing market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 25.0%million in 2024.

South America Cell therapy Processing Market Analysis

According to Cognitive Market Research, the global Cell therapy Processing market size was estimated at USD 4715.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 235.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Cell therapy Processing market size was valued at USD 100.91million in 2024 and is projected to grow at a CAGR of 23.2%during the forecast period. Cell therapy Processing flourished in Brazil due to increasing investments in healthcare infrastructure and a rising demand for advanced medical treatments.
• Argentina's Cell therapy Processing market had a market share of USD 39.61million in 2024 and is projected to grow at a CAGR of 23.5%during the forecast period. Argentina's increasing investments in healthcare infrastructure and a rising demand for advanced medical treatments.
• Colombia Cell therapy Processing market is projected to witness growth at a CAGR of 22.4%during the forecast period, with a market size of USD 20.98million in 2024.
• Peru Cell therapy Processing market is projected to witness growth at a CAGR of 22.8%during the forecast period, with a market size of USD 19.33million in 2024.
• Chile Cell therapy Processing market is projected to witness growth at a CAGR of 22.9%during the forecast period, with a market size of USD 16.98million in 2024.
• The Rest of Latin America's Cell therapy Processing market is projected to witness growth at a CAGR of 21.7%during the forecast period, with a market size of USD 37.96million in 2024.

Middle East Cell therapy Processing Market Analysis

According to Cognitive Market Research, the global Cell therapy Processing market size was estimated at USD 4715.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 94.31 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.9% from 2024 to 2031..

• The GCC Countries Cell therapy Processing market is projected to witness growth at a CAGR of 23.7%during the forecast period, with a market size of USD 40.36million in 2024. Cell therapy Processing sales flourish due to the increasing healthcare investments, expanding research initiatives, and a rising focus on advanced therapeutic solutions.
• The Egypt Cell therapy Processing market is projected to witness growth at a CAGR of 23.2%during the forecast period, with a market size of USD 9.90million in 2024.
• The South Africa Cell therapy Processing market is projected to witness growth at a CAGR of 23.9%during the forecast period, with a market size of USD 14.90million in 2024. Cell therapy Processing sales flourished in South Africa due to increasing healthcare investments, expanding research initiatives, and a rising focus on advanced therapeutic solutions.
• The Turkey Cell therapy Processing market is projected to witness growth at a CAGR of 22.4%during the forecast period, with a market size of USD 8.11 million in 2024.
• The Nigeria Cell therapy Processing market is projected to witness growth at a CAGR of 22.0%during the forecast period, with a market size of USD 9.90million in 2024.
• The Rest of the MEA Cell therapy Processing market is projected to witness growth at a CAGR of 21.9%during the forecast period, with a market size of USD 11.13million in 2024.

Cell therapy Processing Market Analysis

How are Segments Performing in the Global Cell therapy Processing Market?

Cell therapy Processing Market Offering Type Segment Analysis

According to Cognitive Market Research, the Products segment is the dominant category due to the increasing demand for specialized cell culture media, reagents, and kits used in cell isolation, expansion, and differentiation. These products are essential for both research and commercial-scale production of cell therapies. Their widespread use in various therapeutic areas, such as cancer treatment and regenerative medicine, makes them a vital component in the development of advanced therapies.

The Services segment is the fastest-growing category in the Cell Therapy Processing Market. This growth is driven by the increasing demand for outsourced manufacturing and cell processing services provided by contract development and manufacturing organizations (CDMOs). These services help companies scale up production, comply with regulatory standards, and optimize the efficiency of cell therapy processes.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cell therapy Processing Industry. Request a Free Sample PDF!

Cell therapy Processing Market Application Segment Analysis

According to Cognitive Market Research, The Cancer application segment is the dominant category in the Cell Therapy Processing Market, driven by the increasing prevalence of cancer worldwide and the rising demand for innovative treatments. Cell therapies, particularly immunotherapies like CAR-T (Chimeric Antigen Receptor T-cell) therapies, have shown promising results in treating various cancers, which contributes to the segment’s dominance.

The Neurological Disorders application segment is the fastest-growing in the Cell Therapy Processing Market due to the increasing focus on developing regenerative therapies for diseases like Alzheimer's, Parkinson's, and spinal cord injuries. The growing prevalence of neurological disorders, coupled with advances in stem cell research and gene therapies, is propelling the demand for cell-based treatments.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion